Here are relevant reports on : application-development-software-market
-
Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030
Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Geospatial Solutions Market by Technology (Earth Observation, Scanning), Solution (Hardware, Software, Service), End-User (Utility, Business, Transportation, Defense & Intelligence, Infrastructural Development), Application, Region – Global Forecast to 2024
The geospatial solutions market is expected to grow from USD 239.1 billion in 2019 to 502.6 billion by 2024, at a compound annual growth rate (CAGR) of 13.2% during the forecast period.The report includes the profiles of some of the top players in the geospatial solutions market to enable an in-depth understanding of the competitive landscape. Some of the key players are HERE (the Netherlands), Esri (US), Hexagon (Sweden), Atkins Plc (UK), Pitney Bowes (US), Topcon (Japan), DigitalGlobe Inc (Maxar Group) (US), General Electric (US), Harris Corporation (US), Google (US), Bentley (UK), Geospatial Corporation (US), Baidu (China), Telenav (US), TomTom International B.V. (the Netherlands), Apple (US), Oracle (US), Microsoft (US), Amazon (US), IBM (US), SAP (US), China Geo-Engineering Corporation (CGC) (China), RMSI (India), and Orbital Insights (US). The leading players are adopting various strategies to increase their share in the geospatial solutions market.
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Infrastructure Solution Market & Integration Services by Solution (Cloud Computing, Software Development, Desktop & IT Support, Backup & Recovery), & by Integration Services (Cloud Architecture, Data Center Networking, Server/Storage/Security Integration) - Global Forecast - 2019
The Infrastructure Solution market and Integration Services is setting apositive market trend. These solution and services provide various benefits such asincreased customer satisfaction, less time to market for launch of new services, better manageability, and economies of scale.The infrastructure solution and integration services offer increased ability to handle more number of customer transactions. The increasing adoption of Infrastructure Solution and Integration Services by Small and Medium Enterprise, with limited resources they have, has significantly contributed to the growth of the market. The global Infrastructure Solution and Integration Services market is expected to grow with the CAGR of 14.23% from 2014 to 2019.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
High Throughput Process Development Market by Product (Consumables (Minicolumn, Mini Bioreactor), Instruments), Services, Software, Molecule Type (mAB), Technology (Affinity Chromatography), End User (Biopharmaceutical) - Global Forecast to 2021
The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 212.1 Million in 2016, at a CAGR of 14.4% from 2016 to 2021. Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Cloud-Based Application Development Services Market : Worldwide Market Forecast and Analysis (2014-2019)
Businesses around the world are facing stiff competition with numerous players rapidly joining their respective market space. . A business entity, therefore, needs to stay ahead of the competition as well as undergo changes in accordance with the changing market dynamics. It needs to build an intelligent operational framework in order to achieve sustainability. Companies are thus moving towards custom enterprise applications to improve business performance and meet unique business requirements. Enterprises are swiftly turning to cloud technologies for various operational changes since the past six to seven years. The major reasons behind the large scale demand for cloud-based enterprise applications have been the massive scalability and reduced operational costs offered by the cloud services. The scalability and extensible architectures offered by cloud-based applications support complete business availability for global customers, as it reduces development cycles and risks to a minimum. The major service types involved in the market are application consulting, customization, testing, integration, and other services such as training, support, and maintenance. The market revenues are considered from the total application development spending over private, public, and hybrid clouds. Security considerations in the public cloud differ substantially from that in a private cloud. This factor is considered to be a major constraint for the public cloud deployment segment during the forecast.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Preclinical Models In Drug Discovery & Development Market - 2019 By Types, Application & Geography
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Saudi Arabia Cloud Computing Market by Service Model (IaaS (Compute, Storage, Networking), PaaS (Application Development & Integration, Database & Data Analytics & Reporting), SaaS (CRM, SCM, Collaboration & Productivity)), Impact of AI - Forecast to 2030
The market is expected to grow from USD 5,069.5 million in 2025 to USD 14,608.9 million by 2030, at a CAGR of 23.6%. The major players in the Saudi Arabia cloud computing market include Microsoft (US), Google (US), IBM (US), AWS (US), Oracle (US), Salesforce (US), Tencent Cloud (China), SAP (Germany), Alibaba Cloud (China), Adobe (US), Zain Cloud (Kuwait), NourNet (Saudi Arabia), STC (Saudi Arabia), Sahara Net (Saudi Arabia), and NashirNet (Saudi Arabia).
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030
The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
